Skip to content
Search

Latest Stories

Market Exit: PCSE takes over administration of pharmacy premises withdrawal

Market Exit: PCSE takes over administration of pharmacy premises withdrawal

Any pharmacy premises withdrawal requests submitted before 1st July 2024 will still be processed directly by the respective integrated care board  

From today, Primary Care Support England (PCSE) will manage the administration and processing of notices of withdrawal from a pharmaceutical list.


Pharmacy and dispensing appliance contractors who wish to withdraw their premises must now submit closure notification forms to PCSE, which will forward them to the relevant integrated care board (ICB).

Withdrawal notices should be sent to pcse.marketentry@nhs.net.

NHS England announced PCSE's new role last week.

For permanent closure of premises, pharmacies with 40 core opening hours, those with more than 40 core opening hours under a direction, and dispensing appliance contractors are required to give a minimum notice period of three months.

Pharmacies that operate or have operated under the 100-hour condition must provide at least six months' notice.

Under regulation 67 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended, if it is impracticable for contractors to provide the required notice period, they must inform NHS England (or the ICB in whose area the premises are located from 1 April 2023) as soon as it is practicable to do so.

Additionally, the ICB can agree to a shorter notice period.

Closure of premises notification should be completed by contractors where they wish to withdraw premises from a pharmaceutical list. This form is not applicable to contractors operating under a local pharmaceutical services (LPS) contract or dispensing doctors looking to withdraw premises from a dispensing doctor list.

Any withdrawal requests submitted before 1 July 2024 will still be processed directly by the ICB, and any related inquiries should be addressed to the respective ICB.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less